These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27111844)

  • 1. Elastase-like Activity Is Dominant to Chymotrypsin-like Activity in 20S Proteasome's β5 Catalytic Subunit.
    Bensinger D; Neumann T; Scholz C; Voss C; Knorr S; Kuckelkorn U; Hamacher K; Kloetzel PM; Schmidt B
    ACS Chem Biol; 2016 Jul; 11(7):1800-4. PubMed ID: 27111844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of fluorinated phenylalanine generates highly specific inhibitor of proteasome's chymotrypsin-like sites.
    Geurink PP; Liu N; Spaans MP; Downey SL; van den Nieuwendijk AM; van der Marel GA; Kisselev AF; Florea BI; Overkleeft HS
    J Med Chem; 2010 Mar; 53(5):2319-23. PubMed ID: 20131905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibitor of proteasome's caspase-like sites sensitizes cells to specific inhibition of chymotrypsin-like sites.
    Britton M; Lucas MM; Downey SL; Screen M; Pletnev AA; Verdoes M; Tokhunts RA; Amir O; Goddard AL; Pelphrey PM; Wright DL; Overkleeft HS; Kisselev AF
    Chem Biol; 2009 Dec; 16(12):1278-89. PubMed ID: 20064438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic characterization of the chymotryptic activity of the 20S proteasome.
    Stein RL; Melandri F; Dick L
    Biochemistry; 1996 Apr; 35(13):3899-908. PubMed ID: 8672420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death.
    Sanchez G; Berrios D; Olmedo I; Pezoa J; Riquelme JA; Montecinos L; Pedrozo Z; Donoso P
    PLoS One; 2016; 11(8):e0161068. PubMed ID: 27529620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of green tea polyphenols affects their binding to and inhibitory poses of the proteasome beta5 subunit.
    Daniel KG; Landis-Piwowar KR; Chen D; Wan SB; Chan TH; Dou QP
    Int J Mol Med; 2006 Oct; 18(4):625-32. PubMed ID: 16964415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin, chrysin, and luteolin selectively inhibit chymotrypsin-like and trypsin-like proteasome catalytic activities in tumor cells.
    Wu YX; Fang X
    Planta Med; 2010 Feb; 76(2):128-32. PubMed ID: 19653143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel non-covalent inhibitors selective to the β5-subunit of the human 20S proteasome.
    Xu K; Wang K; Yang Y; Yan DA; Huang L; Chen CH; Xiao Z
    Eur J Med Chem; 2015 Jun; 98():61-8. PubMed ID: 26005024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoprotective effects of proteasome beta5 subunit overexpression in lens epithelial cells.
    Liu Y; Liu X; Zhang T; Luna C; Liton PB; Gonzalez P
    Mol Vis; 2007 Jan; 13():31-8. PubMed ID: 17262013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasome.
    Arba M; Nur-Hidayat A; Ruslin ; Yusuf M; Sumarlin ; Hertadi R; Wahyudi ST; Surantaadmaja SI; Tjahjono DH
    Comput Biol Chem; 2018 Jun; 74():230-238. PubMed ID: 29674291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach.
    Groll M; Huber R
    Biochim Biophys Acta; 2004 Nov; 1695(1-3):33-44. PubMed ID: 15571807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicolor monitoring of the proteasome's catalytic signature.
    Priestman MA; Wang Q; Jernigan FE; Chowdhury R; Schmidt M; Lawrence DS
    ACS Chem Biol; 2015 Feb; 10(2):433-40. PubMed ID: 25347733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors.
    Ettari R; Bonaccorso C; Micale N; Heindl C; Schirmeister T; Calabrò ML; Grasso S; Zappalà M
    ChemMedChem; 2011 Jul; 6(7):1228-37. PubMed ID: 21506279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening.
    Di Giovanni C; Ettari R; Sarno S; Rotondo A; Bitto A; Squadrito F; Altavilla D; Schirmeister T; Novellino E; Grasso S; Zappalà M; Lavecchia A
    Eur J Med Chem; 2016 Oct; 121():578-591. PubMed ID: 27318981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes.
    Loidl G; Groll M; Musiol HJ; Ditzel L; Huber R; Moroder L
    Chem Biol; 1999 Apr; 6(4):197-204. PubMed ID: 10099130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Combination Studies of Isoquinolinone AM12 with Curcumin or Quercetin: A New Combination Strategy to Synergistically Inhibit 20S Proteasome.
    Di Chio C; Previti S; Starvaggi J; De Luca F; Calabrò ML; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic Changes in the Activities and Contents of Particular Proteasome Forms in the Cerebral Cortex of C57BL/6 Mice during Aging].
    Burov AV; Funikov SY; Astakhova TM; Teterina EV; Nebogatikov VO; Erokhov PA; Ustyugov AA; Karpov VL; Morozov AV
    Mol Biol (Mosk); 2023; 57(5):886-894. PubMed ID: 37752653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of peptidomimetic boronates as proteasome inhibitors.
    Micale N; Ettari R; Lavecchia A; Di Giovanni C; Scarbaci K; Troiano V; Grasso S; Novellino E; Schirmeister T; Zappalà M
    Eur J Med Chem; 2013 Jun; 64():23-34. PubMed ID: 23639651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
    Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
    J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells.
    Naujokat C; Berges C; Höh A; Wieczorek H; Fuchs D; Ovens J; Miltz M; Sadeghi M; Opelz G; Daniel V
    Immunology; 2007 Jan; 120(1):120-32. PubMed ID: 17083604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.